{"id":79478,"date":"2026-07-17T17:45:48","date_gmt":"2026-07-17T12:15:48","guid":{"rendered":"https:\/\/www.nextias.com\/ca\/?p=79478"},"modified":"2026-07-17T17:46:59","modified_gmt":"2026-07-17T12:16:59","slug":"india-bioeconomy-roadmap","status":"publish","type":"post","link":"https:\/\/www.nextias.com\/ca\/current-affairs\/17-07-2026\/india-bioeconomy-roadmap","title":{"rendered":"India\u2019s Bioeconomy Roadmap 2035"},"content":{"rendered":"\n<p><strong>Syllabus: GS3\/Economy<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Context<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>NITI Aayog has recently announced the <strong>Roadmap for Building India<\/strong> as a <strong>Leading BioEconomy Powerhouse by 2035.<\/strong> The roadmap offers a detailed strategy to <strong>make India one of the top three biotechnology powers<\/strong> in the world by 2035.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Key Highlights of the Roadmap<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>India\u2019s Ambitious Bioeconomy Targets:<\/strong> Grow from $10 billion in 2014 and <strong>$195.3 billion in 2025 (4.8% to national GDP)<\/strong> to $691 billion by 2035, and <strong>$2.6 trillion by 2047.<\/strong>\n<ul class=\"wp-block-list\">\n<li>Create more than 30 million high-value jobs in biotechnology, healthcare, agriculture, industrial biotechnology and the environment.<\/li>\n\n\n\n<li>Transform India into a research led ecosystem and <strong>global biotech innovation and manufacturing hub.<\/strong><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img data-dominant-color=\"e6e9ee\" data-has-transparency=\"false\" loading=\"lazy\" decoding=\"async\" width=\"929\" height=\"428\" src=\"https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2026\/07\/image-171.png\" alt=\"india\u2019s bioeconomy roadmap 2035\" class=\"not-transparent wp-image-79479\" style=\"--dominant-color: #e6e9ee; aspect-ratio:2.1706302741551258;width:512px;height:auto\" srcset=\"https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2026\/07\/image-171.png 929w, https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2026\/07\/image-171-300x138.png 300w, https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2026\/07\/image-171-768x354.png 768w\" sizes=\"auto, (max-width: 929px) 100vw, 929px\" \/><\/figure>\n<\/div>\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img data-dominant-color=\"e6e9ee\" data-has-transparency=\"false\" loading=\"lazy\" decoding=\"async\" width=\"929\" height=\"428\" src=\"https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2026\/07\/image-171.png\" alt=\"\" class=\"not-transparent wp-image-79480\" style=\"--dominant-color: #e6e9ee; aspect-ratio:2.1706302741551258;width:507px;height:auto\" srcset=\"https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2026\/07\/image-171.png 929w, https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2026\/07\/image-171-300x138.png 300w, https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2026\/07\/image-171-768x354.png 768w\" sizes=\"auto, (max-width: 929px) 100vw, 929px\" \/><\/figure>\n<\/div>\n\n\n<ul class=\"wp-block-list\">\n<li><strong>BioEconomy Growth Fund (2026-35) of \u20b950,000 crore:<\/strong> It will bridge the \u2018valley of death\u2019 in the biotechnology sector between lab research and commercial production.\n<ul class=\"wp-block-list\">\n<li>The fund will support <strong>Viability Gap Funding (VGF)<\/strong>, shared biomanufacturing infrastructure and emerging sectors such as advanced therapeutics, synthetic biology, fermentation technologies, diagnostics and biomanufacturing, as well as investing in blended finance and equity-risk instruments.<\/li>\n\n\n\n<li>Further, a <strong>dedicated Production Linked Incentive (PLI) Scheme<\/strong> has been recommended to boost domestic biomanufacturing, reduce import dependence and enhance global competitiveness.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Six National BioMissions<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The roadmap recommends six mission-mode programmes to ensure focused implementation:\n<ul class=\"wp-block-list\">\n<li><strong>GeneIndia: <\/strong>Affordable gene and cell therapies; precision medicine and genomic healthcare.<\/li>\n\n\n\n<li><strong>AgriBio 2.0: <\/strong>Climate-resilient gene-edited crops; biofertilisers and biological crop protection.<\/li>\n\n\n\n<li><strong>BioX Foundry: <\/strong>Commercialisation of synthetic biology innovations; and bio-based manufacturing platforms.<\/li>\n\n\n\n<li><strong>One Health Grid: <\/strong>Integrated surveillance of infectious diseases; monitoring antimicrobial resistance (AMR); and human-animal-environment health integration.<\/li>\n\n\n\n<li><strong>Marine Biotechnology Mission: <\/strong>Expansion of seaweed cultivation; and marine bio-products and blue bioeconomy.<\/li>\n\n\n\n<li><strong>BioPharmaNext: <\/strong>Global hub for biologics and biosimilars; and AI-enabled drug discovery and vaccine innovation.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Institutional and Regulatory Reforms<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Empowered Committee on National BioMissions<\/strong> for inter-ministerial coordination.<\/li>\n\n\n\n<li><strong>National BioData Council<\/strong> to govern biological and health data.<\/li>\n\n\n\n<li><strong>BioEconomy Investment and Policy Forum<\/strong> to align public and private investments.<\/li>\n\n\n\n<li><strong>BioIP and Innovation Evaluation Agency<\/strong> for biotechnology intellectual property valuation and commercialisation.<\/li>\n\n\n\n<li>It recommends:\n<ul class=\"wp-block-list\">\n<li>Fast-track approval pathways for gene therapies, synthetic biology products, and AI-designed drugs.<\/li>\n\n\n\n<li>Modernisation of the <strong>Central Drugs Standard Control Organisation (CDSCO)<\/strong>.<\/li>\n\n\n\n<li>Development of <strong>five integrated bio-innovation clusters<\/strong> with shared manufacturing facilities and high-performance computing under the <strong>National Supercomputing Mission<\/strong>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Significance<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The roadmap recognizes biotechnology as <strong>strategic national infrastructure<\/strong>, similar to digital public infrastructure and energy systems.<\/li>\n\n\n\n<li>It seeks to integrate Artificial Intelligence (AI), robotics, computational biology, and automated biofoundries.<\/li>\n\n\n\n<li>Such convergence may significantly shorten research timelines, improve manufacturing efficiency, strengthen healthcare resilience, facilitate sustainable agriculture and enhance India\u2019s competitiveness in the global bioeconomy.<\/li>\n\n\n\n<li>The proposals are in sync with national priorities under<strong> BioE3 Policy, Atmanirbhar Bharat, Make in India, Startup India<\/strong> and India\u2019s aspiration to be a global innovation hub.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Challenges<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Limited risk capital for biotech startups.<\/li>\n\n\n\n<li>Lack of synergy between academe and industry.<\/li>\n\n\n\n<li>Regulatory delays of new technologies.<\/li>\n\n\n\n<li>Insufficient biomanufacturing infrastructure.<\/li>\n\n\n\n<li>Fragmented governance of biological and health data.<\/li>\n\n\n\n<li>Shortage of highly skilled inter-disciplinary work force.<\/li>\n\n\n\n<li>The<strong> Genome India Project <\/strong>has produced rich genomic datasets, but better data-sharing mechanisms and interoperable digital health infrastructure are needed to convert such data to clinical research.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Way Forward<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The success of the roadmap will depend on execution in mission mode, coordinated governance and sustained public-private partnerships. The priority should be to:\n<ul class=\"wp-block-list\">\n<li>Operationalising the BioEconomy Growth Fund.<\/li>\n\n\n\n<li>Launching the six BioMissions with measurable outcomes.<\/li>\n\n\n\n<li>Strengthening of biotechnology R&amp;D and commercialisation.<\/li>\n\n\n\n<li>Expand bio-innovation clusters and shared infrastructure.<\/li>\n\n\n\n<li>Fostering responsible data governance and accelerating regulatory approval.<\/li>\n\n\n\n<li>Developing a globally competitive biotechnology workforce.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>If implemented well, the roadmap can make biotechnology a major engine of India\u2019s economic growth, health security, food security, climate resilience and technology leadership, while fulfilling the<strong> Viksit Bharat 2047 <\/strong>vision.<\/li>\n<\/ul>\n\n\n\n<p><a href=\"https:\/\/www.thehindu.com\/news\/national\/niti-aayog-proposes-50000-crore-fund-to-make-india-global-biotech-power\/article71230184.ece\/amp\/\" target=\"_blank\" rel=\"noopener\">Source: TH<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p><strong> Context <\/strong><\/p>\n<li class=\"ms-5\"> NITI Aayog has recently announced the Roadmap for Building India as a Leading BioEconomy Powerhouse by 2035. The roadmap offers a detailed strategy to make India one of the top three biotechnology powers in the world by 2035. <\/li>\n<p><\/p>\n<p><strong> Key Highlights of the Roadmap <\/strong><\/p>\n<li class=\"ms-5\"> India\u2019s Ambitious Bioeconomy Targets: Grow from $10 billion in 2014 and $195.3 billion in 2025 (4.8% to national GDP) to $691 billion by 2035, and $2.6 trillion by 2047. <\/li>\n<li class=\"ms-5\"> Create more than 30 million high-value jobs in biotechnology, healthcare, agriculture, industrial biotechnology and the environment. <\/li>\n<p><a href=\" https:\/\/www.nextias.com\/ca\/current-affairs\/17-07-2026\/india-bioeconomy-roadmap \" class=\"btn btn-primary btn-sm float-end\">Read More<\/a><\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-79478","post","type-post","status-publish","format-standard","hentry","category-current-affairs"],"acf":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts\/79478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/comments?post=79478"}],"version-history":[{"count":3,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts\/79478\/revisions"}],"predecessor-version":[{"id":79484,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts\/79478\/revisions\/79484"}],"wp:attachment":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/media?parent=79478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/categories?post=79478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/tags?post=79478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}